| Expression pattern: |
DN |
| Associated gene: |
METTL3, RPS6KB1 mRNA, RPS6KB1 |
| Associated microRNA: |
- |
| Biological function: |
Functions as a tumor suppressor in DDP-resistant NSCLC by suppressing proliferation, promoting apoptosis and autophagy, inhibiting glycolysis, suppressing tumor growth, and reversing or enhancing sensitivity to cisplatin. |
| Molecular mechanism: |
METTL3-mediated m6A modification suppresses hsa_circ_0003176 expression and reduces its stability; hsa_circ_0003176 directly binds to and destabilizes RPS6KB1 mRNA, attenuating mTORC1 signaling and regulating autophagy, glycolysis, apoptosis, proliferation, and DDP resistance. |
| Biological pathway or process: |
autophagy (promotes); glycolysis (inhibits); apoptosis (promotes); proliferation (inhibits); m6A modification (other); mRNA stability (inhibits); drug resistance (inhibits); chemoresistance (inhibits); other pathway/process (inhibits) |
| Detected method: |
Q
|
| Validation methods: |
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; RT-qPCR; Bioinformatics Analysis; MeRIP / MeRIP-seq; RIP (RNA Immunoprecipitation); Actinomycin D / DRB Stability Assay; Transfection; MTT; Annexin V/PI Flow Cytometry; Western Blot; In Vivo Animal Model |
| Clinical significance: |
- |
| Description: |
hsa_circ_0003176 is downregulated in DDP-resistant NSCLC cells and acts as a tumor suppressor that inhibits proliferation and glycolysis, promotes apoptosis and autophagy, and reverses cisplatin resistance. METTL3-mediated m6A modification suppresses hsa_circ_0003176 expression, while hsa_circ_0003176 directly destabilizes RPS6KB1 mRNA to attenuate mTORC1-related malignant and chemoresistant phenotypes. |
| Confidence score: |
0.7609 |